The treatment of advanced renal cell cancer with high-dose oral thalidomide
Open Access
- 2 October 2001
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 85 (7) , 953-958
- https://doi.org/10.1054/bjoc.2001.2025
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Hypothesis: Thalidomide embryopathy?proposed mechanism of actionTeratology, 2000
- Thalidomide — A Revival StoryNew England Journal of Medicine, 1999
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Inflammatory Bowel Disease ManagementDrugs, 1997
- Reciprocal paracrine interactions between tumour cells and endothelial cells: the ‘angiogenesis progression’ hypothesisEuropean Journal Of Cancer, 1996
- Prurigo nodularis and photosensitivity in AIDS: Treatment with thalidomideJournal of the American Academy of Dermatology, 1995
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Rapid Cytokine Release in Cancer Patients Treated with Interleukin-2Journal of Immunotherapy, 1992
- Interleukin-6 and renal cell cancer: Production, regulation, and growth effectsCancer Immunology, Immunotherapy, 1992
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971